Douglas Pippin Email & Phone Number

Exton, Pa, Us

Exton, Pa

In 2015, Dr. Pippin founded Praeventix, LLC. an integrated biopharmaceutical company focusing on the discovery, development and marketing of novel signal transduction modulating agents for the treatment of Inflammatory Bowel Disease disorders in unmet clinical indications.

Exton, Pa

In 2010, Dr. Pippin founded PuriSpec, LLC, a company focused on the spectrographic analysis and purification of diverse sets of compounds with the use of supercritical fluid chromatography/mass spectrometry (SFC/MS) for numerous applications in drug discovery.

Chester Springs, Pa

In 2013, Dr. Pippin co-founded ChemTech Environmental Solutions, LLC, a green chemistry based enterprise developing proprietary environmentally friendly solutions directly applied to PA Department of Transportation, SEPTA and PA Turnpike Commission chemistry sourcing contracts.

Exton, Pa

In 2012, Dr. Pippin co-founded Theraceutix, LLC. as a commercial dermatology products based company focusing on the development and marketing of proprietary topically administered OTC skin protectants and cosmetic solutions in unmet clinical indications to the public sector.

Exton, Pa

In 2010, Dr. Pippin founded TransSig, Inc. a virtually integrated biopharmaceutical company focusing on the discovery, development and marketing of novel signal transduction modulating agents for the treatment of cellular proliferation and metabolic disorders in unmet clinical indications.

Co-founded Toph Biologicals, Inc. as a diagnostic biomarker assay development company focusing on the development and marketing of reagents and assays for screening in the treatment and prevention of cellular proliferation disorders in unmet clinical indications.

--Identification/Development of novel IP based lead candidates in Research Drug Discovery division targeting CNS, Oncology, and Inflammation/Autoimmune diseases.--Responsible for identifying and negotiating CMO contracts for expansion of Cephalon high throughput screening deck.--Provide strategy for emerging Translational Medicine division in identifying new opportunities for existing and expansion of IP base.--Provide managerial support for outsourcing campaigns with CMO’s to deliver novel material for early project development.--Member of information management solutions team identifying and evaluating independent software vendors for chemistry research.

--Senior Research Scientist responsible for development/implementation of strategy for intellectual property generation directly contributing to a $500M+ exclusive global strategic alliance with Tier 1 pharma to discover, develop, manufacture and commercialize therapeutics in treatment of multiple oncology and autoimmune indications.--Co-inventor of anti-angiogenic/anti-oncogenic signal transduction modulator that has advanced to Phase II.--Member of multiple Drug Development teams at CGI involving close collaborations with HTS and biology.--Responsible for the development of proprietary fully integrated HSAC platform capable of synthesizing and purifying 1000+ compounds per day in high yield and purity.--Design, synthesis, and optimization of proprietary kinase inhibitor libraries targeted against multiple targets. Lead ID and subsequent LO for CGI’s Auto-immune/Auto-inflammation and oncology projects generating key SAR leading directly to compounds for advancement into in-vivo studies.

Commercial Real Estate Development

--Establish and effectively communicate primary goals of the Board--Responsible for effective asset utilization for maximizing software development and deployment..--Responsible for identification and immediate defusion of all visible, or suspected, live crisises.--Maintain complete competitive analysis for POB, Inc. portfolio (6, 12 and 24 month view).--Responsible for review of all general/administrative operations and implimentaon of policy.--Reponsible for updating business plan for current internal clarity and banking/capital formation needs.--Address all Regulatory / Legal / Litigation issues.--Responsible for supporting development of proprietary informatics platform.

--Responsible for planning and execution of strategic plan--Responsible for maintaining market dominance from present market leadership--Responsible for development of proprietary informatics platform.--Responsible for executive team development.--Driving change, accountability, and excellence

Ph.D., Synthetic Organic Chemistry

Education record

Education record